Inhibition of phosphatase and tensin homolog deleted on chromosome 10 decreases rat cortical neuron injury and blood-brain barrier permeability, and improves neurological functional recovery in traumatic brain injury model

PLoS One. 2013 Nov 28;8(11):e80429. doi: 10.1371/journal.pone.0080429. eCollection 2013.

Abstract

Background and purpose: Recent evidence has supported the neuroprotective effect of bpV (pic), an inhibitor of phosphatase and tensin homolog deleted on chromosome 10 (PTEN), in models of ischemic stroke. However, whether PTEN inhibitors improve long-term functional recovery after traumatic brain injury (TBI) and whether PTEN affects blood brain barrier (BBB) permeability need further elucidation. The present study was performed to address these issues.

Methods: Adult Sprague-Dawley rats were subjected to fluid percussion injury (FPI) after treatment with a well-established PTEN inhibitor bpV (pic) or saline starting 24 h before FPI. Western blotting, real-time quantitative PCR, or immunostaining was used to measure PTEN, p-Akt, or MMP-9 expression. We determined the presence of neuron apoptosis by TUNEL assay. Evans Blue dye extravasation was measured to evaluate the extent of BBB disruption. Functional recovery was assessed by the neurological severity score (NSS), and Kaplan-Meier analysis was used for survival analysis.

Results: PTEN expression was up-regulated after TBI. After bpV (pic) treatment, p-Akt was also up-regulated. We found that bpV (pic) significantly decreased BBB permeability and reduced the number of TUNEL-positive cells. We further demonstrated that PTEN inhibition improved neurological function recovery in the early stage after TBI.

Conclusion: These data suggest that treatment with the PTEN inhibitor bpV (pic) has a neuroprotective effect in TBI rats.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Apoptosis / genetics
  • Blood-Brain Barrier / metabolism*
  • Brain Injuries / genetics
  • Brain Injuries / metabolism*
  • Brain Injuries / mortality
  • Brain Injuries / pathology*
  • Brain Injuries / rehabilitation
  • Cerebral Cortex / metabolism
  • Cerebral Cortex / pathology
  • Chromosomes, Mammalian
  • Disease Models, Animal
  • Gene Expression Regulation / drug effects
  • Male
  • Microfilament Proteins / antagonists & inhibitors*
  • Microfilament Proteins / genetics
  • Neurons / metabolism*
  • Organometallic Compounds / pharmacology
  • PTEN Phosphohydrolase / antagonists & inhibitors
  • PTEN Phosphohydrolase / genetics
  • PTEN Phosphohydrolase / metabolism
  • Permeability / drug effects
  • Phosphoprotein Phosphatases / antagonists & inhibitors*
  • Phosphoprotein Phosphatases / genetics
  • Proto-Oncogene Proteins c-akt / metabolism
  • Rats
  • Recovery of Function
  • Tensins

Substances

  • Microfilament Proteins
  • Organometallic Compounds
  • Tensins
  • Tns1 protein, rat
  • oxodiperoxo(pyridine-2-carboxylate)vanadate(V)
  • Proto-Oncogene Proteins c-akt
  • Phosphoprotein Phosphatases
  • PTEN Phosphohydrolase

Grants and funding

Grant support was provided by National Nature and Science Foundation of China (grant No. 81271383) and the Shanghai Science and Technique Committee (grant No. 13411951400, 13411951401 and 10JC1412500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.